Many therapeutic approaches to malignant exophthalmos have been reported, but none of them has gained sufficient acceptance to be regarded as a standard method of therapy. Systemic administration of steroids in large quantities (prednisolone 60-120 mg/day) often improves orbital inflammatory signs. Improvement of ophthalmoplegia, papilledema and optic neuritis have also been reported (Brown et al., 1963; Werner, 1966) . Recently, highly coliimated supervoltage radiation of the retro-orbital space has been applied, with seemingly rapid and beneficial effects, to infiltrative and inflammatory manifestations (Donaldson et al., 1973; Corvington et al., 1977) . On the other hand, Teng et al., (1980) reported somewhat disappointing results in that only 25% of the patients had improved proptosis after orbital radiotherapy. Dandona et al. (1981) tried plasmapheresis for the treatment of exophthalmos and reported it to be effective. Danowski et al. (1971) suggested that prescription of adequate doses of thyroid hormone at the time of treatment of thyrotoxicosis is beneficial. The present study reports our results with steroid therapy, supervoltage orbital radiotherapy, plasmapheresis and thyroxine replacement therapy in 13 patients with moderately severe ophthlamopathy.
Materials and Methods
Thirteen patients (9 males and 4 females) were diagnosed as having malignant exophthalmos, according to the diagnostic criteria of Hormone Receptor Disease Research Committee, Japan (Torizuka et al., 1981) . All patients complained of chemosis, ocular pain and diplopia. The mean value for proptosis was 21.3 mm (ranging from 18-23 mm). They had marked hypertrophy of the extraocular muscles on ultrasonograph. The mean value for the muscle et al. 
Results
All patients subjected to this series of treatments were euthyroid under antithyroid patients. Five patients had previous steroid therapy and 2 had prior plasmapheresis. The remaining 2 patients were judged not to be appropriate for steroid therapy because they had had manifestations of ophthalmopathy for more than 3 years. Of 9 patients, 4 achieved good results, one a fair result and 4 no response.
In 5 patients with good or fair results, the Hertel reading significantly decreased after the radiation therapy (Table 2) . It should be noticed that the Hertel reading after the radiation therapy was still greater than that in Graves' disease patients without infiltrative ophthalmopathy.
The same results were obtained from the examination of the Endocrinol. Japon. August 1982 changes in muscle index during the orbital radiation therapy (Table 2 ). The patients who had been treated within 12 months of deterioration showed a better response to the therapy than those who had ophthalmopathy for a longer period. The effect of radiation therapy on the symptoms of the orbital soft tissue involvement (ocular pain, chemosis and epiphora) appeared after 3 or 4 weeks of therapy. On the other hand, the improvement in proptosis appeared 3-7 months after therapy. TSH level decreased to the undetectable range. During the course of treatment, there was no significant change in proptosis. The correlation of changes in Hertel reading and the muscle index during the therapy of malignant exophthalmos was analyzed. The 2 parameters were significantly correlated (r=0.728, p<0.001).
In 6 patients with malignant exophthalmos, the 2 parameters changed in parallel (Figure 3) .
Discussion
With the therapeutic regimens used in this study, 84.6% of the patients showed some improvement, but the effect was mostly on the symptoms of orbital soft tissue involvements. Donaldson et al. (1973) reported the efficacy of orbital radiotherapy in 91. 3% and Corvington et al. (1977) in 71.4% of patients.
Recently, however, Teng et al. (1980) reported somewhat disappointing results. Only 35% showed some response and 25% improved minimally. Only 25% of the patients had improved proptosis. In our study, the effects on proptosis were also rather unsatisfactory. In six patients (46.2%) proptosis decreased by 2.3 mm on the average. It should be emphasized that they still had noticeable exophthalmos as compared to Graves' disease patients without infitrative ophthalmopathy. It is sometimes observed that the symptoms of Graves' ophthalmopathy naturally improve during antithyroid drug therapy. We previously compared the extraocular muscle change in a group of untreated patients and that of treated patients (Yamamoto et al., 1979) . The extraocular muscle of euthyroid patients on antithyroid drugs was similar to that in untreated patients. Therefore, we felt that the significant decrease in proptosis and muscle index after orbital radiotherapy was a valid effect of the treatment.
For regression of proptosis, radiation therapy is the most beneficial among the therapeutic regimens used in this study, especially in patients who received the treatment shortly after the development of malignant exophthalmos. The effect of the radiation can be divided roughly into 2 categories, namely the early effects and the delayed effects. The effect on the soft tissue changes appeared 3-4 weeks after radiation therapy, while the effect on the proptosis appeared after 6 months. An early appearence of the effects of radiation therapy has been reported (Donaldson et al., 1973; Corvington et al., 1977) , but in these reports no description of the effect on the proptosis is given. Steroid therapy was effective on the symptoms of orbital soft tissue involvement such as ocular pain, epiphora, chemosis and lid swelling. The results appeared within 3-4 weeks of the therapy. As for the proptosis, however, the steroid therapy was not effective except in one patient. Plasmapheresis showed a clear and immediate effect in a patient treated with prednisolone. The effect was characterized by an immediate improvement in proptosis. Since the response was transient, the therapy was thought to be beneficial for acute complications of the disease such as optic neuropathy, aggravation of exophthalmos, and ulceration of the cornea.
Permanent remission should be maintained by simultaneous (or successive) steroid therapy or orbital radiation therapy. The potential risk of exacerbation of ophthalmopathy after thyroid ablative therapy has been emphasized. It has been proposed that this is due to sudden release of thyroid antigen. In this study, 11 patients (84.6%) had deterioration of ophthalmopathy during the antithyroid treatment. In the early stage of the deterioration, thyroxine replacement was useful for ameliorating diplopia or ocular pain. No effect of replacement therapy was observed on proptosis.
We have suggested the utility of the muscle index in diagnosis and following the progress of exophthalmos in Graves' disease (Yamamoto et al., 1979) . The validity of the parameter is proven in this study by the positive correlation between the changes in the muscle index and Hertel readings during therapy of malignant exophthalmos. By measuring the index, an objective judgement of the effect of the therapy becomes possible.
In conclusion, radiation to retro-orbital space is the most beneficial therapy for improving diplopia and proptosis. It should be performed in the early stage of deterioration of ophthalmopathy to get a satisfactory effect. Orbital echography is useful in detecting progressive changes in the retroorbital space.
